Ximing Xu

2.1k total citations
101 papers, 1.6k citations indexed

About

Ximing Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ximing Xu has authored 101 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 47 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ximing Xu's work include Cancer Immunotherapy and Biomarkers (20 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (10 papers). Ximing Xu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Cancer-related molecular mechanisms research (12 papers) and MicroRNA in disease regulation (10 papers). Ximing Xu collaborates with scholars based in China, United States and Australia. Ximing Xu's co-authors include Wei Ge, Dedong Cao, Huilin Xu, Tao Guo, Xiaoqin He, Yongfa Zheng, Junjian Deng, Xinyao Hu, Jiayu Chen and Hua Zhu and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ximing Xu

86 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ximing Xu China 24 896 599 527 324 198 101 1.6k
Chenyue Zhang China 22 680 0.8× 465 0.8× 578 1.1× 303 0.9× 198 1.0× 74 1.4k
Federica Papaccio Italy 21 1.0k 1.1× 594 1.0× 909 1.7× 293 0.9× 185 0.9× 42 2.0k
Xian Lin China 23 1.2k 1.4× 637 1.1× 476 0.9× 181 0.6× 166 0.8× 63 1.7k
Takaaki Masuda Japan 25 1.1k 1.3× 775 1.3× 603 1.1× 397 1.2× 212 1.1× 102 2.0k
Hao‐Xiang Wu China 22 520 0.6× 393 0.7× 596 1.1× 289 0.9× 251 1.3× 38 1.3k
Mina Maftouh Iran 26 1.2k 1.4× 752 1.3× 648 1.2× 189 0.6× 197 1.0× 39 1.9k
Xia Luo China 20 936 1.0× 697 1.2× 619 1.2× 454 1.4× 315 1.6× 48 1.9k
Ludovica Ciuffreda Italy 21 1.4k 1.5× 549 0.9× 668 1.3× 373 1.2× 233 1.2× 41 2.0k
Lisha Qi China 28 1.4k 1.6× 893 1.5× 585 1.1× 415 1.3× 201 1.0× 71 2.4k
Beiyuan Hu China 13 883 1.0× 613 1.0× 330 0.6× 159 0.5× 178 0.9× 20 1.3k

Countries citing papers authored by Ximing Xu

Since Specialization
Citations

This map shows the geographic impact of Ximing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ximing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ximing Xu more than expected).

Fields of papers citing papers by Ximing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ximing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ximing Xu. The network helps show where Ximing Xu may publish in the future.

Co-authorship network of co-authors of Ximing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ximing Xu. A scholar is included among the top collaborators of Ximing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ximing Xu. Ximing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ran, Hao, Jianmin Huang, Xintong Zhang, et al.. (2025). P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD. Journal of Crohn s and Colitis. 19(Supplement_1). i1618–i1618. 1 indexed citations
2.
Ran, Haitao, Dongyang Liu, Yuwei Zhou, et al.. (2025). AI-guided Generation and Development of HXN-1011, A Highly Potent Anti-TSLP Biparatopic Antibody. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7443–A7443. 1 indexed citations
3.
Ran, Haitao, Jianmin Huang, Dong Lin, et al.. (2025). Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1382–A1382. 2 indexed citations
4.
Huang, Jianyong, Dong Lin, Di Liu, et al.. (2025). AI-guided Engineering and Generation of Bispecific Antibodies Targeting Both IL13 and TSLP for Chronic Respiratory Diseases. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1361–A1361. 1 indexed citations
5.
Sun, Xuan, Qingtong Yu, Kaili Wang, et al.. (2024). Lycium barbarum oligosaccharide-derived carbon quantum dots inhibit glial scar formation while promoting neuronal differentiation of neural stem cells. International Journal of Biological Macromolecules. 282(Pt 6). 137474–137474. 2 indexed citations
6.
Wang, Zhe, Xuan Sun, Wenwen Deng, et al.. (2024). Nasal mucosa-derived mesenchymal stem cells prolonged the survival of septic rats by protecting macrophages from pyroptosis. Cellular Immunology. 401-402. 104840–104840. 2 indexed citations
7.
Xu, Ximing, Ran Li, Peng Fu, et al.. (2024). Platelet Membrane‐Coated Curcumin‐PLGA Nanoparticles Promote Astrocyte‐Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment. Small. 20(42). e2311128–e2311128. 12 indexed citations
8.
Li, Yuan, et al.. (2024). Copper homeostasis and cuproptosis in radiation-induced injury. Biomedicine & Pharmacotherapy. 178. 117150–117150. 4 indexed citations
9.
Hu, Yi, Cairong Li, Jiayu Chen, et al.. (2023). Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway. Cancers. 15(6). 1850–1850. 17 indexed citations
10.
Hu, Xinyao, Dan Li, Hua Zhu, et al.. (2023). ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma. BMC Medical Genomics. 16(1). 188–188. 6 indexed citations
11.
12.
He, Xiaoqin, Junjian Deng, Wenliang Chen, et al.. (2022). ROS‐Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment. Oxidative Medicine and Cellular Longevity. 2022(1). 4713518–4713518. 6 indexed citations
13.
Xu, Huilin, et al.. (2021). Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis. International Immunopharmacology. 100. 108135–108135. 7 indexed citations
14.
He, Xinjia, et al.. (2020). Identification of a novel immune prognostic model in gastric cancer. Clinical & Translational Oncology. 23(4). 846–855. 13 indexed citations
15.
He, Xiaoqin, Jiajun Yu, Lin Xiong, et al.. (2019). Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR. Gene. 719. 144044–144044. 20 indexed citations
16.
Wang, Yugang, Donghui Zheng, Min Shi, & Ximing Xu. (2018). T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysis. Journal of Medical Genetics. 56(1). 22–28. 12 indexed citations
17.
Yuan, Guangjin, et al.. (2010). Whole-field intensity-modulated radiation therapy (IMRT) combined with replanning split-field IMRT for nasopharygeal carcinoma. 2010 3rd International Conference on Biomedical Engineering and Informatics. 1364–1368.
18.
Wang, Lingling, Jiarui Bi, Yao Chen, et al.. (2010). Annexin A1 expression and its prognostic significance in human breast cancer. Neoplasma. 57(3). 253–259. 45 indexed citations
19.
Yang, Yufan, et al.. (2008). An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. Diseases of the Esophagus. 21(5). 395–401. 17 indexed citations
20.
Yu, Honggang, Yaowei Ai, Liang Yu, et al.. (2007). Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. International Journal of Cancer. 122(2). 433–443. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenyue Zhang Breakdown of academic impact, for papers by Federica Papaccio Breakdown of academic impact, for papers by Xian Lin Breakdown of academic impact, for papers by Takaaki Masuda Breakdown of academic impact, for papers by Hao‐Xiang Wu Breakdown of academic impact, for papers by Mina Maftouh Breakdown of academic impact, for papers by Xia Luo Breakdown of academic impact, for papers by Ludovica Ciuffreda Breakdown of academic impact, for papers by Lisha Qi Breakdown of academic impact, for papers by Beiyuan Hu
Rankless by CCL
2026